These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 27384875)

  • 1. YBX1 regulates tumor growth via CDC25a pathway in human lung adenocarcinoma.
    Zhao S; Wang Y; Guo T; Yu W; Li J; Tang Z; Yu Z; Zhao L; Zhang Y; Wang Z; Wang P; Li Y; Li F; Sun Z; Xuan Y; Tang R; Deng WG; Guo W; Gu C
    Oncotarget; 2016 Dec; 7(50):82139-82157. PubMed ID: 27384875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. YB-1 regulates tumor growth by promoting MACC1/c-Met pathway in human lung adenocarcinoma.
    Guo T; Zhao S; Wang P; Xue X; Zhang Y; Yang M; Li N; Li Z; Xu L; Jiang L; Zhao L; Ma PC; Rosell R; Li J; Gu C
    Oncotarget; 2017 Jul; 8(29):48110-48125. PubMed ID: 28624808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-99a-5p suppresses breast cancer progression and cell-cycle pathway through downregulating CDC25A.
    Qin H; Liu W
    J Cell Physiol; 2019 Apr; 234(4):3526-3537. PubMed ID: 30443946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulatory mechanism of interaction between Y-box-binding protein 1 and heterogenous nuclear ribonucleoprotein K in cell division cycle 25a signal pathway and lung cancer metastasis.
    Fu L; Yang M; Ma Y
    Cell Mol Biol (Noisy-le-grand); 2023 Dec; 69(14):62-68. PubMed ID: 38279484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Yifei Sanjie formula alleviates lung cancer progression via regulating PRMT6-YBX1-CDC25A axis.
    Tang J; Yin C; Chen M; Dong M; Xu Y
    Environ Toxicol; 2024 May; 39(5):3225-3237. PubMed ID: 38357781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of NMI promotes tumor growth and predicts poor prognosis in human lung adenocarcinomas.
    Wang J; Zou K; Feng X; Chen M; Li C; Tang R; Xuan Y; Luo M; Chen W; Qiu H; Qin G; Li Y; Zhang C; Xiao B; Kang L; Kang T; Huang W; Yu X; Wu X; Deng W
    Mol Cancer; 2017 Oct; 16(1):158. PubMed ID: 29025423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA LINC00472 regulates cell stiffness and inhibits the migration and invasion of lung adenocarcinoma by binding to YBX1.
    Deng X; Xiong W; Jiang X; Zhang S; Li Z; Zhou Y; Xiang B; Zhou M; Li X; Li G; Zeng Z; Gong Z
    Cell Death Dis; 2020 Nov; 11(11):945. PubMed ID: 33144579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cleavage and polyadenylation specific factor 4 targets NF-κB/cyclooxygenase-2 signaling to promote lung cancer growth and progression.
    Yi C; Wang Y; Zhang C; Xuan Y; Zhao S; Liu T; Li W; Liao Y; Feng X; Hao J; Gao Y; Yu W; Chen Y; Zhang C; Guo W; Tang B; Deng W
    Cancer Lett; 2016 Oct; 381(1):1-13. PubMed ID: 27450326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of HMGA1 deregulates tumor growth via cdc25A and alters migration/invasion through a cdc25A-independent pathway in medulloblastoma.
    Lau KM; Chan QK; Pang JC; Ma FM; Li KK; Yeung WW; Cheng AS; Feng H; Chung NY; Li HM; Zhou L; Wang Y; Mao Y; Ng HK
    Acta Neuropathol; 2012 Apr; 123(4):553-71. PubMed ID: 22249617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-184 Deregulated by the MicroRNA-21 Promotes Tumor Malignancy and Poor Outcomes in Non-small Cell Lung Cancer via Targeting CDC25A and c-Myc.
    Lin TC; Lin PL; Cheng YW; Wu TC; Chou MC; Chen CY; Lee H
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1532-9. PubMed ID: 25990966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA DSCAM-AS1 interacts with YBX1 to promote cancer progression by forming a positive feedback loop that activates FOXA1 transcription network.
    Zhang Y; Huang YX; Wang DL; Yang B; Yan HY; Lin LH; Li Y; Chen J; Xie LM; Huang YS; Liao JY; Hu KS; He JH; Saw PE; Xu X; Yin D
    Theranostics; 2020; 10(23):10823-10837. PubMed ID: 32929382
    [No Abstract]   [Full Text] [Related]  

  • 12. Long intergenic non-coding RNA 00152 promotes lung adenocarcinoma proliferation via interacting with EZH2 and repressing IL24 expression.
    Chen QN; Chen X; Chen ZY; Nie FQ; Wei CC; Ma HW; Wan L; Yan S; Ren SN; Wang ZX
    Mol Cancer; 2017 Jan; 16(1):17. PubMed ID: 28109288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysregulated Expression of the MicroRNA miR-137 and Its Target YBX1 Contribute to the Invasive Characteristics of Malignant Pleural Mesothelioma.
    Johnson TG; Schelch K; Cheng YY; Williams M; Sarun KH; Kirschner MB; Kao S; Linton A; Klebe S; McCaughan BC; Lin RCY; Pirker C; Berger W; Lasham A; van Zandwijk N; Reid G
    J Thorac Oncol; 2018 Feb; 13(2):258-272. PubMed ID: 29113949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Y-box binding protein-1 promotes tumorigenesis and progression via the epidermal growth factor receptor/AKT pathway in spinal chordoma.
    Liang C; Ma Y; Yong L; Yang C; Wang P; Liu X; Zhu B; Zhou H; Liu X; Liu Z
    Cancer Sci; 2019 Jan; 110(1):166-179. PubMed ID: 30426615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CDC25A mRNA levels significantly correlate with Ki-67 expression in human glioma samples.
    Yamashita Y; Kasugai I; Sato M; Tanuma N; Sato I; Nomura M; Yamashita K; Sonoda Y; Kumabe T; Tominaga T; Katakura R; Shima H
    J Neurooncol; 2010 Oct; 100(1):43-9. PubMed ID: 20217459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Silencing of Long Noncoding RNA
    Su W; Feng S; Chen X; Yang X; Mao R; Guo C; Wang Z; Thomas DG; Lin J; Reddy RM; Orringer MB; Chang AC; Yang Z; Beer DG; Chen G
    Cancer Res; 2018 Jun; 78(12):3207-3219. PubMed ID: 29669758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long noncoding RNA AWPPH promotes hepatocellular carcinoma progression through YBX1 and serves as a prognostic biomarker.
    Zhao X; Liu Y; Yu S
    Biochim Biophys Acta Mol Basis Dis; 2017 Jul; 1863(7):1805-1816. PubMed ID: 28428004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. YBX1 mediates autophagy by targeting p110β and decreasing the sensitivity to cisplatin in NSCLC.
    Cui Y; Li F; Xie Q; Zhao S; Guo T; Guo P; Hu S; Hao J; Tian C; Yu W; Li Z; Fang L; Zhao L; Chen M; Wu T; Gu C
    Cell Death Dis; 2020 Jun; 11(6):476. PubMed ID: 32561752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RAN and YBX1 are required for cell proliferation and IL-4 expression and linked to poor prognosis in oral squamous cell carcinoma.
    Che X; Liu M; Li D; Li Z; Guo J; Jia R
    Exp Cell Res; 2021 Sep; 406(2):112767. PubMed ID: 34364882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptional coactivator CBP upregulates hTERT expression and tumor growth and predicts poor prognosis in human lung cancers.
    Guo W; Lu J; Dai M; Wu T; Yu Z; Wang J; Chen W; Shi D; Yu W; Xiao Y; Yi C; Tang Z; Xu T; Xiao X; Yuan Y; Liu Q; Du G; Deng W
    Oncotarget; 2014 Oct; 5(19):9349-61. PubMed ID: 25294805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.